A Study of the Impact of TRS-483 Recommended Correction Factors for Dosimetry of Small Fields in Flattening Filter Free Beams used in TrueBeam Linear Accelerators

• Main Authors: Gopinath Mamballikalam, Senthil kumar, Clinto C.O, Jaon bos R.C., Ahamed Basith P.M.
• Format: Article
• Language: English
• Published: Mashhad University of Medical Sciences 2021-05-01
• Series: Iranian Journal of Medical Physics
• Subjects: fff beams trs; 483 linear accelerator small field dosimetry
• Online Access: https://ijmp.mums.ac.ir/article_16003_fca9f029e208ec3da2954df57f0ccb6e.pdf

Introduction: To study the effect of the International Atomic Energy Agency (IAEA) TRS-483 recommended beam quality correction factor in reference dosimetry and to examine the recommended field output correction factor for relative dosimetry of 6-MV flattening filter free (FFF) small fields, used in a Varian TrueBeam linear accelerator (LINAC). Material and Methods: The beam quality and field output correction for 6-MV FFF beams were adopted from the TRS-483 protocol. Monte Carlo (MC) simulation of the output factor was performed using the PENELOPE-based PRIMO software and compared with the TRS-483 corrected output factors. Two analytical anisotropic algorithm (AAA) models in the EclipseTM treatment planning system (TPS) were created; one with an output factor taken as the ratio of meter readings and one with an output factor obtained by multiplying the TRS-483 correction factor by the ratio of meter readings. Besides, box field and dynamic conformal arc (DCA) plans were created for both AAA models for verification and validation. The patient-specific quality assurances (QA) for ten different targets were performed, and deviations between the measured and TPS-calculated point doses in both models were examined. Results: Separate beam quality correction factors for FFF beams in the TRS-483 protocol only resulted in an improvement of 0.1% in reference dosimetry. The TRS-483 corrected output factor was in a better agreement with the MC-calculated output factor. For a patient-specific QA of DCA plans, the output factor-corrected AAA dose calculation algorithm showed a better agreement between the measured and simulated doses. Also, there was a smaller deviation (1.2%) for the smallest target of 0.23 cc (8 mm equivalent sphere diameter) used in this study. Conclusion:The field output factors for the LINAC small beams can be improved by incorporating the TRS-483 correction factors. However, the extent of improvement that can be expected depends on the source model of the calculation algorithm and how these well-generalized corrections are suitable for user beams and detectors.